CNBX Pharmaceuticals Inc. SEC filings CNBX
CNBX Pharmaceuticals Inc. has 301 filings in SEC EDGAR's recent list, going back to Jan 9, 2006. Its latest annual report, Form 10-K, was filed on Dec 1, 2025 for the period ended Aug 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jun 24, 2026, covering the quarter ended May 31, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (auditor change). The company's fiscal year ends on August 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Jun 24, 2026 | May 31, 2026 |
| 10-Q | Quarterly report | Apr 14, 2026 | Feb 28, 2026 |
| 10-Q | Quarterly report | Jan 14, 2026 | Nov 30, 2025 |
| 10-Q | Quarterly report | Jul 14, 2025 | May 31, 2025 |
| 10-Q | Quarterly report | Apr 14, 2025 | Feb 28, 2025 |
| 10-Q | Quarterly report | Jan 13, 2025 | Nov 30, 2024 |
| 10-Q | Quarterly report | Jul 15, 2024 | May 31, 2024 |
| 10-Q | Quarterly report | Apr 16, 2024 | Feb 29, 2024 |
| 10-Q | Quarterly report | Jan 12, 2024 | Nov 30, 2023 |
| 10-Q | Quarterly report | Jul 14, 2023 | May 31, 2023 |
| 10-Q | Quarterly report | Apr 14, 2023 | Feb 28, 2023 |
| 10-Q | Quarterly report | Jan 13, 2023 | Nov 30, 2022 |
| 10-Q | Quarterly report | Jul 14, 2022 | May 31, 2022 |
| 10-Q | Quarterly report | Apr 12, 2022 | Feb 28, 2022 |
| 10-Q | Quarterly report | Jan 13, 2022 | Nov 30, 2021 |
| 10-Q | Quarterly report | Jul 14, 2021 | May 31, 2021 |
| 10-Q | Quarterly report | Apr 14, 2021 | Feb 28, 2021 |
| 10-Q | Quarterly report | Jan 14, 2021 | Nov 30, 2020 |
| 10-Q | Quarterly report | Jul 14, 2020 | May 31, 2020 |
| 10-Q | Quarterly report | Apr 13, 2020 | Feb 29, 2020 |
| 10-Q | Quarterly report | Jan 14, 2020 | Nov 30, 2019 |
| 10-Q | Quarterly report | Jul 15, 2019 | May 31, 2019 |
| 10-Q | Quarterly report | Apr 15, 2019 | Feb 28, 2019 |
| 10-Q | Quarterly report | Jan 17, 2019 | Nov 30, 2018 |
| 10-Q | Quarterly report | Jul 16, 2018 | May 31, 2018 |
| 10-Q | Quarterly report | Apr 5, 2018 | Feb 28, 2018 |
| 10-Q | Quarterly report | Jan 16, 2018 | Nov 30, 2017 |
| 10-Q | Quarterly report | Jul 17, 2017 | May 31, 2017 |
| 10-Q | Quarterly report | Apr 14, 2017 | Feb 28, 2017 |
| 10-Q | Quarterly report | Jan 17, 2017 | Nov 30, 2016 |
| 10-Q | Quarterly report | Jul 13, 2016 | May 31, 2016 |
| 10-Q | Quarterly report | Apr 18, 2016 | Feb 29, 2016 |
| 10-Q/A | Amended quarterly report | Apr 8, 2016 | Nov 30, 2015 |
| 10-Q | Quarterly report | Jan 22, 2016 | Nov 30, 2015 |
| 10-Q/A | Amended quarterly report | Nov 17, 2015 | May 31, 2015 |
| 10-Q/A | Amended quarterly report | Nov 17, 2015 | Feb 28, 2015 |
| 10-Q/A | Amended quarterly report | Nov 17, 2015 | Nov 30, 2014 |
| 10-Q | Quarterly report | Jul 15, 2015 | May 31, 2015 |
| 10-Q/A | Amended quarterly report | Jul 15, 2015 | Feb 28, 2015 |
| 10-Q | Quarterly report | Apr 20, 2015 | Feb 28, 2015 |
| 10-Q | Quarterly report | Jan 20, 2015 | Nov 30, 2014 |
| 10-Q/A | Amended quarterly report | Jul 15, 2014 | May 31, 2014 |
| 10-Q | Quarterly report | Jul 14, 2014 | May 31, 2014 |
| 10-Q | Quarterly report | Apr 1, 2014 | Feb 28, 2014 |
| 10-Q/A | Amended quarterly report | Jan 15, 2014 | Nov 30, 2013 |
| 10-Q | Quarterly report | Jan 14, 2014 | Nov 30, 2013 |
| 10-Q | Quarterly report | Jul 15, 2013 | May 31, 2013 |
| 10-Q | Quarterly report | Apr 15, 2013 | Feb 28, 2013 |
| 10-Q | Quarterly report | Jan 14, 2013 | Nov 30, 2012 |
| 10-Q | Quarterly report | Jul 6, 2012 | May 31, 2012 |
| 10-Q | Quarterly report | Apr 13, 2012 | Feb 29, 2012 |
| 10-Q | Quarterly report | Jan 13, 2012 | Nov 30, 2011 |
| 10-Q | Quarterly report | Jul 21, 2011 | May 31, 2011 |
| 10-Q | Quarterly report | Apr 14, 2011 | Feb 28, 2011 |
| 10-Q | Quarterly report | Jan 18, 2011 | Nov 30, 2010 |
| 10-Q | Quarterly report | Jul 13, 2010 | May 31, 2010 |
| 10-Q/A | Amended quarterly report | Jun 1, 2010 | Feb 28, 2010 |
| 10-Q/A | Amended quarterly report | May 28, 2010 | Nov 30, 2009 |
| 10-Q | Quarterly report | Apr 15, 2010 | Feb 28, 2010 |
| 10-Q | Quarterly report | Jan 14, 2010 | Nov 30, 2009 |
| 10-Q | Quarterly report | Jul 10, 2009 | May 31, 2009 |
| 10-Q | Quarterly report | Apr 14, 2009 | Feb 28, 2009 |
| 10-Q | Quarterly report | Jan 13, 2009 | Nov 30, 2008 |
Showing 63 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CNBX (OTC)
- Fiscal year ends
- August 31
- Incorporated in
- NV
- Headquarters
- Bethesda, MD
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1343009
- Former names
- Cannabics Pharmaceuticals Inc. (until Mar 16, 2022); American Mining Corp (until May 1, 2014); Thrust Energy Corp. (until May 10, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.